Erratum: Evaluating the impact of age on immune checkpoint therapy biomarkers (Cell Reports (2021) 36(8), (S2211124721010378), (10.1016/j.celrep.2021.109599))

Rossin Erbe, Zheyu Wang, Sharon Wu, Joanne Xiu, Neeha Zaidi, Jennifer La, David Tuck, Nathanael Fillmore, Nicolas A. Giraldo, Michael Topper, Stephen Baylin, Marc Lippman, Claudine Isaacs, Reva Basho, Ilya Serebriiskii, Heinz Josef Lenz, Igor Astsaturov, John Marshall, Josephine Taverna, Jerry LeeElizabeth M. Jaffee, Evanthia T. Roussos Torres, Ashani Weeraratna, Hariharan Easwaran, Elana J. Fertig

Producción científica: Comment/debaterevisión exhaustiva

3 Citas (Scopus)

Resumen

(Cell Reports 36, 109599-1–109599-12.e1–e4; August 24, 2021) In the originally published version of this article, Hariharan Easwaran should have been listed as a corresponding author. The designation is now applied here and with the article online. The production team apologizes for the error.

Idioma originalEnglish (US)
Número de artículo110033
PublicaciónCell Reports
Volumen37
N.º7
DOI
EstadoPublished - nov 16 2021

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Huella

Profundice en los temas de investigación de 'Erratum: Evaluating the impact of age on immune checkpoint therapy biomarkers (Cell Reports (2021) 36(8), (S2211124721010378), (10.1016/j.celrep.2021.109599))'. En conjunto forman una huella única.

Citar esto